Showing 1 - 2 results of 2 for search 'A. Hasbini', query time: 0.02s Refine Results
  1. 1
    Late toxicity and quality of life from GETUG-AFU 22 study: A randomized phase II trial comparing 6 months of degarelix in combination with radiotherapy to radiotherapy alone for patients with detectable PSA after radical prostatectomy

    Late toxicity and quality of life from GETUG-AFU 22 study: A randomized phase II trial comparing 6 months of degarelix in combination with radiotherapy to radiotherapy alone for pa... by P. Sargos, S. Guerif, J. Fraisse, E. Meyer, S. Supiot, E. Lagneau, E. Deniaud-Alexandre, P. Rochin, A. Benyoucef, L. Cartier, H. Hamidou, A. Hasbini, G. Crehange, P. Pommier, G. De Laroche, S. Pelissier, E. Gross, P. Fourneret, L. Salomon, I. Latorzeff

    Published 2020-07-01
    Get full text
    Article
  2. 2
    Stereotactic body radiation therapy for spine and non-spine bone metastases. GETUG (french society of urological radiation oncologists) recommendations using a national two-round modified Delphi survey

    Stereotactic body radiation therapy for spine and non-spine bone metastases. GETUG (french society of urological radiation oncologists) recommendations using a national two-round m... by F. Vilotte, D. Pasquier, P. Blanchard, S. Supiot, J. Khalifa, U. Schick, T. Lacornerie, L. Vieillevigne, D. Marre, O. Chapet, I. Latorzeff, N. Magne, E. Meyer, K. Cao, Y. Belkacemi, J.E. Bibault, M. Berge-Lefranc, J.C. Faivre, K. Gnep, V. Guimas, A. Hasbini, J. Lagrand-Escure, C. Hennequin, P. Graff

    Published 2022-11-01
    Get full text
    Article

Search Tools: